Stevanato Group (NYSE:STVN) specializes in the production and distribution of pharmaceutical packaging and drug delivery systems. Its operations span across the development of glass vials, syringes, and diagnostic components, aiming to enhance the efficacy, safety, and delivery of healthcare treatments. Stevanato's projects are dedicated to supporting the pharmaceutical and biotech industries with state-of-the-art solutions for medication administration and storage, focusing on innovation and sustainability to meet the evolving needs of patients and healthcare providers worldwide. The company’s objectives are geared towards expanding its global reach, improving product quality, and contributing to the advancement of the pharmaceutical sector through continuous research and development.